Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Factors influencing treatment response and outcome of first-episode schizophrenia: implications for understanding the pathophysiology of schizophrenia.

Lieberman JA, Koreen AR, Chakos M, Sheitman B, Woerner M, Alvir JM, Bilder R.

J Clin Psychiatry. 1996;57 Suppl 9:5-9. Review.

PMID:
8823344
2.

Gender and schizophrenia.

Tamminga CA.

J Clin Psychiatry. 1997;58 Suppl 15:33-7. Review.

PMID:
9427875
3.

[Therapeutic strategies in the first psychotic episode].

Douki S, Taktak MJ, Ben Zineb S, Cheour M.

Encephale. 1999 Nov;25 Spec No 3:44-51. Review. French.

PMID:
10598294
4.

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches.

Lieberman JA, Perkins D, Belger A, Chakos M, Jarskog F, Boteva K, Gilmore J.

Biol Psychiatry. 2001 Dec 1;50(11):884-97. Review. Erratum in: Biol Psychiatry 2002 Feb 15;51(4):346.

PMID:
11743943
5.

[Oxidative stress involvement in schizophrenia pathophysiology: a review].

Fendri C, Mechri A, Khiari G, Othman A, Kerkeni A, Gaha L.

Encephale. 2006 Mar-Apr;32(2 Pt 1):244-52. Review. French.

PMID:
16910626
6.

The natural history and pathophysiology of treatment resistant schizophrenia.

Sheitman BB, Lieberman JA.

J Psychiatr Res. 1998 May-Aug;32(3-4):143-50. Review.

PMID:
9793867
7.

The role of negative symptoms and cognitive dysfunction in schizophrenia outcome.

Tamminga CA, Buchanan RW, Gold JM.

Int Clin Psychopharmacol. 1998 Mar;13 Suppl 3:S21-6. Review.

PMID:
9690966
8.

Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia.

Lieberman JA.

J Clin Psychiatry. 1999;60 Suppl 12:9-12. Review.

9.

Utilization of long-acting antipsychotic medication in patient care.

Kane JM.

CNS Spectr. 2006 Dec;11(12 Suppl 14):1-7; quiz 7-8. Review.

PMID:
17146411
10.

Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?

DeQuardo JR, Tandon R.

J Psychiatr Res. 1998 May-Aug;32(3-4):229-42. Review.

PMID:
9793876
11.

Treatment-resistant schizophrenia--the role of clozapine.

Meltzer HY.

Curr Med Res Opin. 1997;14(1):1-20. Review.

PMID:
9524789
12.

The staging model in schizophrenia, and its clinical implications.

Agius M, Goh C, Ulhaq S, McGorry P.

Psychiatr Danub. 2010 Jun;22(2):211-20. Review.

13.

[Psychopathology of schizophrenia and brain imaging].

Gross G, Huber G.

Fortschr Neurol Psychiatr. 2008 May;76 Suppl 1:S49-56. doi: 10.1055/s-2008-1038152. Review. German.

PMID:
18461545
14.

Progressive structural brain changes in schizophrenia.

Puri BK.

Expert Rev Neurother. 2010 Jan;10(1):33-42. doi: 10.1586/ern.09.142. Review.

PMID:
20021319
15.

Sex differences in schizophrenia.

Abel KM, Drake R, Goldstein JM.

Int Rev Psychiatry. 2010;22(5):417-28. doi: 10.3109/09540261.2010.515205. Review.

PMID:
21047156
16.

[Schizophrenia: neurodevelopmental disorder or degenerative brain process?].

Gross G, Huber G.

Fortschr Neurol Psychiatr. 2008 May;76 Suppl 1:S57-62. doi: 10.1055/s-2008-1038153. Review. German.

PMID:
18461546
17.

Cognitive-behavioral therapy for medication-resistant symptoms.

Garety PA, Fowler D, Kuipers E.

Schizophr Bull. 2000;26(1):73-86. Review.

PMID:
10755670
18.

Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions.

Cannon TD, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Huttunen MO, Keshavan MS, Seidman LJ, Tsuang MT.

Schizophr Bull. 2003;29(4):653-69. Review.

PMID:
14989405
19.

The development of treatment resistance in patients with schizophrenia: a clinical and pathophysiologic perspective.

Lieberman JA, Sheitman B, Chakos M, Robinson D, Schooler N, Keith S.

J Clin Psychopharmacol. 1998 Apr;18(2 Suppl 1):20S-4S. Review.

PMID:
9555612
20.

Early detection and intervention with schizophrenia: rationale.

McGlashan TH, Johannessen JO.

Schizophr Bull. 1996;22(2):201-22. Review.

PMID:
8782282

Supplemental Content

Support Center